Descubre y comparte nuestro conocimiento público

World Health Organization. Communicable Diseases Cluster ,  WHO Consultation on Monitoring Antimalarial Drug Resistance (2001 : Geneva, Switzerland) ,  [Surveillance de la résistance aux antipaludiques : rapport d' une consultation de l' OMS, Genève, Suisse, 3-5 décembre 2001]

Phanouvong, S ,  Vrakking, H ,  Blanc, L ,  Wondemagegnehu, E ,  Moore, T ,  Rägo, L ,  Mboussa, J ,  Norval, P ,  Matji, R ,  World Health Organization. Communicable Diseases Cluster ,  [Operational guide for national tuberculosis control programmes on the introduction and use of fixed-dose combination drugs / S. Phanouvong ... [et al.]]

Public-Private Mix Subgroup for DOTS Expansion. Meeting (1st : 2002, Geneva, Switzerland) ,  World Health Organization. Communicable Diseases Cluster ,  Stop TB Partnership ,  [First meeting of the public-private mix subgroup for DOTS expansion : 25-26 November 2002, World Health Organization, Geneva, Switzerland]

DOTS Expansion Working Group. Meeting (3rd : 2002 : Montreal, Que.) ,  World Health Organization. Communicable Diseases Cluster ,  Stop TB Partnership ,  [Final report of the 3rd DOTS Expansion Working Group Meeting : 5-6 October 2002, Montreal, Canada]

World Health Organization. Communicable Diseases Cluster ,  [Avian influenza : assessing the pandemic threat, Grippe aviaire : évaluation du risque de pandémie]

World Health Organization. Communicable Diseases Cluster ,  [The use of indicators for communicable disease control at district level]

World Health Organization. Communicable Diseases Cluster ,  [Instructions for applying to the green light committee for access to second-line anti-tuberculosis drugs]

World Health Organization. Communicable Diseases Cluster ,  [Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for dots-plus]